ARAlireza Rahimi-Mamaghani

Alireza Rahimi-Mamaghani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alireza Rahimi-Mamaghani has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Targeting symptoms of fibromyalgia through transcutaneous electrical nerve stimulation (TENS): a systematic review of current systematic reviews

    by Masoud Sahebari, Fateme Tahmasbi, Alireza Rahimi-Mamaghani

    Background: Fibromyalgia syndrome (FMS) is a chronic condition characterized by widespread musculoskeletal pain, fatigue, and cognitive dysfunction. Considering that current treatments often provide limited relief, interest has grown in non-pharmacological options such as transcutaneous electrical nerve stimulation (TENS). Objective: To systematically and critically assess and synthesize current evidence from systematic reviews and meta-analyses on the efficacy and safety of TENS for managing symptoms of FMS. Methods: An umbrella review was conducted in accordance with the PRISMA 2020 guidelines. Databases including PubMed, Scopus, Embase, Web of Science, and Cochrane Library were searched in April 2024 for systematic reviews and meta-analyses evaluating TENS in adults with FMS. Reviews were included if they reported symptom-related outcomes such as pain, fatigue, sleep, function, or quality of life. Data extraction and risk of bias assessment were performed independently by 2 reviewers. The GRADE approach was used to assess the certainty of evidence, and a narrative synthesis was conducted due to heterogeneity. Results: Nine systematic reviews, encompassing a broad range of TENS protocols and study populations, were included. TENS provided short-term pain relief, particularly when applied at higher intensities in treatment courses of 10 or more sessions. Functional and psychosocial outcomes were inconsistently reported and typically did not show clinically significant improvements. TENS was reported as safe and well-tolerated across all reviews. Methodological quality of the included systematic reviews was predominantly high. However, GRADE assessment indicated low to moderate certainty for pain reduction with TENS, very low to low certainty for functional outcomes, and moderate certainty for its effects on pain modulation in fibromyalgia. Conclusions: While TENS appears to be a safe and potentially effective adjunct for short-term pain relief and enhancing pain modulation, the overall evidence remains limited by inconsistency and low certainty regarding functional improvements.


  • Open Access

    Exploring Therapeutic Potentials of Photobiomodulation Therapy (PBMT) In Urogenital Disorders: A Comprehensive Review

    by Fateme Tahmasbi, Farzin Soleimanzadeh, Reza Aletaha, Alireza Rahimi-Mamaghani

    This comprehensive review aimed to provide an evidence-based overview of the therapeutic potential of photobiomodulation therapy (PBMT) in managing urogenital conditions. A systematic search was conducted in Web of Science, PubMed, Scopus, and Google Scholar using various MeSH terms and keywords, resulting in the identification of 8 preclinical and 14 clinical studies. The findings suggest that PBMT demonstrates promising therapeutic effects in both human studies and animal models by stimulating cellular processes and tissue repair. Although limited by poor penetration with certain devices, PBMT was found to prevent bladder cancer development and improve renal oxidative stress markers in diabetic rats. In humans, PBMT has been shown to improve sperm parameters, manage chronic pelvic diseases, alleviate pain, and enhance pelvic floor muscle strength. These findings indicate that PBMT has broad therapeutic potential for pelvic and urogenital disorders, warranting further research to clarify its mechanisms and long-term efficacy.


  • Application of peripheral electrical stimulation for treatment of erectile dysfunction: a systematic review and meta-analysis

    by Fateme Tahmasbi, Alireza Rahimi-Mamaghani, Farzin Soleimanzadeh, Hanieh Salehi-Pourmehr, Mohsen Mohammad-Rahimi

    Introduction: Erectile dysfunction (ED) is a common and debilitating condition that can have significant impacts on quality of life. Peripheral electrical stimulation (PES) has emerged as a potential alternative therapy for ED, as it aims to improve penile hemodynamics and neuromuscular function. However, the clinical evidence on the effectiveness of PES for managing ED remains unclear. Objective: To conduct a comprehensive systematic review evaluating the effectiveness of PES for the management of ED in adult male patients. Methods: PubMed, Embase, Scopus, Web of Science, and Google Scholar were searched from inception to April 2024 using relevant keywords. Studies evaluating the use of any form of PES for the management of ED in adult male patients were included. Two independent reviewers screened titles and abstracts, retrieved full-text articles, and extracted data using a standardized form. Methodological quality was assessed using the appropriate Joanna Briggs Institute (JBI) checklists. A meta-analysis was conducted using RevMan 5.4.1 software. Results: A total of 13 studies [6 randomized controlled trials (RCTs) and 7 quasi-experimental studies], published from 1998 to 2024, satisfied the inclusion criteria. Studies reported on using different PES techniques, including transcutaneous electrical nerve stimulation (TENS), percutaneous electrical nerve stimulation (PENS), functional electrical stimulation (FES), and transanal pelvic plexus stimulation (TPPS). Six studies were eligible for the meta-analysis. The first analysis, evaluating the before-and-after results of PES on ED, showed a mean difference in International Index of Erectile Function (IIEF) scores of 3.09 (95% CI: -2.19 to 8.38; I2 = 99%), indicating a non-significant improvement in erectile function following PES. The second analysis, comparing the intervention group with a control group, showed a significantly higher mean difference of 6.27 (95% CI: 4.30 to 8.27; I2 = 79%), suggesting a positive effect of PES on erectile function compared to the control group, though moderate heterogeneity was observed. All the studies were of low to moderate quality, and the certainty of the evidence was weak. Conclusion: Limited and low-quality research suggested the potential benefits of PES for treating ED. However, the current evidence is weak and cannot support routine administration. More high-quality research is needed to establish PES optimization.


  • Nonimplantable Peripheral Electrical Stimulation for Management of Chronic Pelvic Pain: An Umbrella Review

    by Fateme Tahmasbi, Alireza Rahimi-Mamaghani, Farzin Soleimanzadeh, Salar Ghaderi, Reza Aletaha, Hanieh Salehi-Pourmehr, Omid Sedigh, Mohsen Mohammad-Rahimi


  • Open Access

    Exploring the effects of transcutaneous electrical nerve stimulation (TENS) in spinal cord injury rehabilitation: A systematic review of systematic reviews

    by Fateme Tahmasbi, Salar Ghaderi, Sarvin Sanaie, Alireza Rahimi-Mamaghani

    Background: Transcutaneous electrical nerve stimulation (TENS) has emerged as a significant intervention in rehabilitating spinal cord injury (SCI). It has shown promising results in restoring function and improving outcomes for individuals with SCI throughout the current evidence. Objectives: To give a thorough recapitulation of the most recent systematic reviews (SRs) on the role of TENS in the rehabilitation of SCI. Method: Several medical databases including MEDLINE (PubMed), Scopus, Web of Science, and Cochrane Library were searched systematically for citations published up until June 2023. Two reviewers thoroughly screened the research, gathered pertinent data, and assessed the caliber of the retrieved evidence. The quality of the SRs was evaluated using the JBI checklist for SRs. Results: Following an initial screening of 736 articles, 16 satisfied the inclusion criteria. TENS showed promising effects for various rehabilitative purposes, including spasticity, pain, motor function, erectile function, and cognitive function with no major adverse effects in SCI patients. Conclusion: This comprehensive overview of the literature outlines the currently available data for the use of TENS in SCI. However, to establish standardized procedures for improving the rehabilitation of SCI, further high-quality investigations are required.


  • The role of transcutaneous electrical nerve stimulation (TENS) in rehabilitation of cerebral palsy: a systematic review

    by Fateme Tahmasbi, Sarvin Sanaie, Hanieh Salehi-Pourmehr, Salar Ghaderi, Alireza Rahimi-Mamaghani

    Cerebral palsy (CP) is one of the most important causes of disability across the globe. Transcutaneous electrical nerve stimulation (TENS) has been proposed as a potential adjunct therapy. This systematic review aims to explore the application of TENS in the rehabilitation of individuals with CP.Methods: A comprehensive literature search was conducted across multiple databases for studies published up to December 2023. Inclusion criteria encompassed clinical studies that evaluated the effects of TENS on rehabilitation outcomes in individuals with CP. Data were extracted and synthesized in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The quality of the included studies was assessed using the appropriate Joanna Briggs Institute (JBI) checklist based on the study design. A total of 11 studies were eligible for entering this systematic review. Studies reported the application of TENS for different CP-induced conditions, including motor function, spasticity, and gait. Following the administration of TENS in CP patients, an overall favorable trend with few to no side effects was reported. Nevertheless, most of the included studies were of low to moderate quality. Although this review offers a comprehensive examination of the use of TENS in CP rehabilitation, the scarcity of high-quality studies indicates that further research is necessary to confirm its efficacy in this population.


  • Investigating iontophoresis as a therapeutic approach for Peyronie’s disease: a systematic review

    by Sahand Eslami, Fateme Tahmasbi, Alireza Rahimi-Mamaghani, Sarvin Sanaie, Carlo Bettocchi, Omid Sedigh, Farzin Soleimanzadeh

    Introduction: Iontophoresis therapy (IPT) is a noninvasive technique that uses electrical impulses to deliver charged molecules into the skin for controlled and targeted drug delivery. IPT has been explored as a noninvasive treatment option for Peyronie’s disease (PD), but the current literature in this regard is still scarce. Objective: We aimed to systematically review the current literature on the application of IPT in the management of PD to provide a comprehensive evaluation and holistic outlook on the subject. Method: A comprehensive search strategy was implemented in the following databases to retrieve research articles: PubMed (MEDLINE), Scopus, and Web of Science. Google Scholar was also manually searched. The search results were imported into Rayyan reference management for assessment based on the predefined inclusion criteria. The quality of the articles was evaluated by the proper JBI checklist (ie, per the study design), and the JBI grades of recommendation were used for grading the evidence. Results: A systematic search yielded 451 publications, 11 of which met the criteria to be included in this systematic review. The results demonstrated that IPT, usually with verapamil and dexamethasone, has shown promising results in treating PD. These methods can reduce pain, plaque size, and penile curvature while improving sexual function and quality of life with no serious adverse events. However, most studies had moderate to low quality, indicating a weak recommendation for a certain health management strategy. Conclusion: Based on the extant literature, there is currently insufficient evidence to support the use of IPT for the management of PD. Placing it in the forefront of research can facilitate the management choices for PD even further, given its therapeutic potential.


  • Open Access

    Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis

    by Mohammad Amin Akbarzadeh, Yosra Vaez-Gharamaleki, Farid Jahanshahlou, Alireza Ghaffari Bavil, Sina Hamzehzadeh, Sina Seifimansour, Alireza Rahimi-Mamaghani, Mohammad-Salar Hosseini

    Since the beginning of the COVID-19 pandemic, complications of this disease among vulnerable populations have been a primary concern. Cancer patients are among the most vulnerable groups of patients owing to the compromised immune system and weakened overall health status1 1 Akbarzadeh MA, Hosseini MS. Implications for cancer care in Iran during COVID-19 pandemic. Radiother Oncol. 2020;148:148:211-2. https://doi.org/10.1016/j.radonc.2020.04.041 https://doi.org/10.1016/j.radonc.2020.04... .


  • Shining a Light on Selenium: a Meta-analysis of Supplementation in Multiple Sclerosis

    by Mehrab Rahmani, Sina Pakkhesal, Saman Baharomid, Hanie Karimi, Reza Mosaddeghi-Heris, Mahnaz Talebi, Negar Aghaei, Alireza Rahimi-Mamaghani, Sarvin Sanaie, Amirreza Naseri

    Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central nervous system. Selenium is a trace element with significant antioxidant activity. This study aimed to seek evidence concerning selenium supplementation in MS. A systematic search was performed on PubMed, Web of Science, Scopus, and Embase databases to identify the studies assessing the consumption rate, efficacy, and safety of selenium and selenium-containing supplementations in MS patients. The meta-analysis was performed using the Comprehensive Meta-Analysis and the risk of bias was evaluated using the Joanna Briggs Institute’s critical appraisal tools. A total of 9 studies were included, which consisted of six studies regarding the rate of selenium supplement consumption in MS patients, with a total sample size of 2381 patients. Based on the quantitative synthesis, 14.3% (95% CI, 12.8–16.0%; I2, 3.58%) of MS patients had current selenium supplements usage, and 11.3% (95% CI, 7.6–16.6%; I2, 81.40%) of patients had used selenium supplements previously. Although there is no evidence regarding supplementation with selenium alone, three RCT studies reported the safety of selenium-containing supplementation use in MS with improved inflammation and oxidative stress conditions. The findings of this study show that over 10% of patients with MS used selenium supplements, with no clinical significance supporting the benefits. There is a lack of evidence regarding the safety and efficacy of selenium supplements in MS patients. Due to the limited number of included studies and the lack of comprehensive and specific studies regarding selenium supplements in MS, the results must be interpreted with caution, and future clinical trials are required.